Skip to main content
logo
Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
62.14
-0.99 (-1.57%)
At close: Nov 6, 2026, 4:00 PM EST
62.47
+0.33 (0.54%)
After-hours: Nov 6, 2026, 7:57 PM EST

BMY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
13,06912,97311,48912,50212,22212,26911,20112,34211,89212,20111,86511,47710,96611,22611,33711,40611,21811,88711,64811,985
Revenue Growth (YoY)
6.93%5.74%2.57%1.30%2.77%0.56%-5.60%7.54%8.44%8.69%4.66%0.62%-2.25%-5.56%-2.67%-4.83%-3.49%1.57%5.19%8.29%
Cost of Revenue
4,1333,7113,4083,5073,3123,3563,0183,2122,8562,9712,9102,7072,4902,8092,5122,5202,2672,5752,4192,356
Gross Profit
8,9369,2628,0818,9958,9108,9138,1839,1309,0369,2308,9558,7708,4768,4178,8258,8868,9519,3129,2299,629
Selling, General & Admin
1,6981,8241,6102,0871,7881,6891,5811,8522,0801,9211,9682,0641,9381,9141,7622,2601,8481,7731,8292,354
Research & Development
2,3642,5362,2382,5612,4332,2622,2362,7882,3532,2952,3462,4762,1782,2522,2062,5102,2582,3002,1332,518
Amortization of Goodwill & Intangibles
4584374378268318308301,6932,4062,4162,3572,2782,2562,2572,2562,3432,4182,4172,4172,417
Operating Expenses
4,5204,7974,2855,4745,0524,7814,6476,3336,8396,6326,6716,8186,3726,4236,2247,1136,5246,4906,3797,277
Operating Income
4,4164,4653,7963,5213,8584,1323,5362,7972,1972,5982,2841,9522,1041,9942,6011,7732,4272,8222,8502,352
Interest Expense
-400-403-406-432-482-485-493-496-509-525-428-318-280-278-285-290-294-306-311-311
Interest & Investment Income
1181011041481611391381149487183145107951028252271039
Earnings From Equity Investments
-602547--37-944-2831-2518-11-20-1-3-54-5017
Currency Exchange Gain (Loss)
11710-1776834-344833-1658144939174822577
Other Non Operating Income (Expenses)
19910612554451642849357592502409551579473516416542431394481
EBT Excluding Unusual Items
4,3344,3463,6543,8114,0604,2453,6992,4822,4222,7232,4632,3632,5422,3222,9531,9972,7722,9422,9502,585
Merger & Restructuring Charges
-2112-38-316-245-343-211-232-276-445-1,089-160-280-265-188-185-239-314-269-151
Gain (Loss) on Sale of Investments
-265410930419015-69-231-55797178-18-47-135166-11-254-594-486
Gain (Loss) on Sale of Assets
-109--1-8---15----------211-
Asset Writedown
--420-410-564-85-300--1,902-47-870-2-89--20--58--40-
Legal Settlements
-3-5-4-10-165-1-257-13--69-2-3617-75-146-44-2537-33
Other Unusual Items
--22-361--336-3116-106--10-61-31079-1819-27532
Pretax Income
2,5364,0863,2391,4703,1141,7722,9711751,6761,286-11,5161,6742,1371,8592,7701,8592,2091,9581,6871,858
Income Tax Expense
37477056138491946050999461-398392-88203-218503-166601529404-514
Earnings From Continuing Operations
2,1623,3162,6781,0862,1951,3122,462761,2151,684-11,9081,7621,9342,0772,2672,0251,6081,4291,2832,372
Minority Interest in Earnings
-1-116-2-6-4-4-4-3--6-4-5-3-2-8-5-
Net Income
2,1623,3172,6771,0872,2011,3102,456721,2111,680-11,9111,7621,9282,0732,2622,0221,6061,4211,2782,372
Net Income to Common
2,1623,3172,6771,0872,2011,3102,456721,2111,680-11,9111,7621,9282,0732,2622,0221,6061,4211,2782,372
Net Income Growth (YoY)
-1.77%153.21%9.00%1409.72%81.75%-22.02%--95.91%-37.19%-18.96%--12.86%20.05%45.88%77.00%-14.75%3.88%34.69%-36.76%-
Shares Outstanding (Basic)
2,0432,0422,0382,0362,0362,0352,0312,0292,0282,0272,0232,0272,0572,0932,0992,1082,1332,1332,1462,202
Shares Outstanding (Diluted)
2,0532,0482,0472,0412,0392,0382,0402,0372,0312,0292,0232,0332,0642,1022,1132,1242,1482,1492,1642,219
Shares Change (YoY)
0.69%0.49%0.34%0.20%0.39%0.44%0.84%0.20%-1.60%-3.47%-4.26%-4.28%-3.91%-2.19%-2.36%-4.28%-4.23%-4.57%-4.46%-1.47%
EPS (Basic)
1.061.621.310.531.080.641.210.040.600.83-5.890.870.940.991.080.960.750.670.601.08
EPS (Diluted)
1.051.621.310.531.080.641.200.040.600.83-5.890.870.930.991.070.950.750.660.591.08
EPS Growth (YoY)
-2.78%153.13%9.17%1392.12%80.86%-22.78%--95.91%-35.79%-16.28%--8.94%24.00%50.00%81.36%-11.43%8.70%40.43%-33.71%-

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
3,8373,0887571,6045,9913,5561,6944,0615,2672,0642,5503,9224,4091,6282,6922,9603,4401,9893,5593,737
Free Cash Flow Per Share
1.871.510.370.792.941.750.831.992.591.021.261.932.140.781.271.391.600.931.651.68
Dividend Per Share
0.6300.6300.6300.6300.6200.6200.6200.6200.6000.6000.6000.6000.5700.5700.5700.5700.5400.5400.5400.540
Dividend Growth (YoY)
1.61%1.61%1.61%1.61%3.33%3.33%3.33%3.33%5.26%5.26%5.26%5.26%5.56%5.56%5.56%5.56%10.20%10.20%10.20%10.20%
Gross Margin
68.38%71.39%70.34%71.95%72.90%72.65%73.06%73.98%75.98%75.65%75.47%76.41%77.29%74.98%77.84%77.91%79.79%78.34%79.23%80.34%
Operating Margin
33.79%34.42%33.04%28.16%31.57%33.68%31.57%22.66%18.48%21.29%19.25%17.01%19.19%17.76%22.94%15.54%21.63%23.74%24.47%19.63%
Profit Margin
16.54%25.57%23.30%8.70%18.01%10.68%21.93%0.58%10.18%13.77%-100.39%15.35%17.58%18.47%19.95%17.73%14.32%11.95%10.97%19.79%
Free Cash Flow Margin
29.36%23.80%6.59%12.83%49.02%28.98%15.12%32.90%44.29%16.92%21.49%34.17%40.21%14.50%23.75%25.95%30.66%16.73%30.55%31.18%
EBITDA
4,7585,0764,4074,5454,9085,1224,5494,6464,8415,1824,7824,4014,5764,4415,0024,2215,0755,3635,4954,987
EBITDA Margin
36.40%39.13%38.36%36.35%40.16%41.75%40.61%37.64%40.71%42.47%40.30%38.35%41.73%39.56%44.12%37.01%45.24%45.12%47.17%41.61%
D&A For EBITDA
341.676116111,0241,0509901,0131,8492,6442,5842,4982,4492,4722,4472,4012,4482,6482,5412,6452,635
EBIT
4,4164,4653,7963,5213,8584,1323,5362,7972,1972,5982,2841,9522,1041,9942,6011,7732,4272,8222,8502,352
EBIT Margin
33.79%34.42%33.04%28.16%31.57%33.68%31.57%22.66%18.48%21.29%19.25%17.01%19.19%17.76%22.94%15.54%21.63%23.74%24.47%19.63%
Effective Tax Rate
14.75%18.84%17.32%26.12%29.51%25.96%17.13%56.57%27.51%---9.50%-18.16%-27.21%27.02%23.95%-
Revenue as Reported
13,06912,97311,48912,50212,22212,26911,20112,34211,89212,20111,86511,47710,96611,22611,33711,40611,21811,88711,64811,985
SEC Filings: 10-K · 10-Q